A detailed history of Intech Investment Management LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Intech Investment Management LLC holds 48,842 shares of AVXL stock, worth $440,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,842
Previous 32,253 51.43%
Holding current value
$440,066
Previous $276,000 63.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$7.37 - $9.63 $122,260 - $159,752
16,589 Added 51.43%
48,842 $450,000
Q1 2025

May 20, 2025

SELL
$7.85 - $13.46 $79,520 - $136,349
-10,130 Reduced 23.9%
32,253 $276,000
Q4 2024

Feb 10, 2025

BUY
$5.11 - $12.56 $96,205 - $236,467
18,827 Added 79.92%
42,383 $455,000
Q3 2024

Nov 08, 2024

BUY
$4.11 - $7.04 $96,815 - $165,834
23,556 New
23,556 $133,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $702M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.